Even though the role of ANO1 expression and gene amplification in tumour progression and metastatic dissemination has been investigated in different cancers, including HNSCC, its potential contribution to malignant transformation has not yet been explored in clinical samples. This evidence concerns the gene ANO1 and cancer.